Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
| ▸ | WNT3A | P56704 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10078874 | 0.75 | CA2 (0.37) | ALDH1A1TDP1CYP2A6 | |
| SCHEMBL25262617 | 0.74 | DAO (0.36) | ALDH1A1CTNNB1WNT3A | |
| SCHEMBL15352797 | 0.72 | ALDH1A1 (0.35) | ALDH1A1TDP1CTNNB1WNT3A | |
| SCHEMBL15242418 | 0.71 | ALDH1A1 (0.33) | ALDH1A1TDP1CTNNB1WNT3A | |
| SCHEMBL26617149 | 0.70 | ALDH1A1 (0.34) | ALDH1A1TDP1CTNNB1WNT3A | |
| SCHEMBL22591301 | 0.70 | ALDH1A1 (0.35) | ALDH1A1TDP1CTNNB1WNT3A | |
| SCHEMBL765343 | 0.70 | ALDH1A1 (0.34) | ALDH1A1TDP1CTNNB1WNT3A | |
| SCHEMBL15674825 | 0.70 | ALDH1A1 (0.41) | ALDH1A1TDP1CTNNB1WNT3A | |
| SCHEMBL28135449 | 0.70 | CTNNB1 (0.34) | ALDH1A1TDP1CTNNB1WNT3A | |
| SCHEMBL28783014 | 0.68 | ALDH1A1 (0.33) | ALDH1A1TDP1CTNNB1WNT3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2460789-B1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2017-04-19 | — | — | EP | disclosed |
| US-9079830-B2 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-07-14 | — | — | US | disclosed |
| EP-2460789-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-06-06 | — | — | EP | disclosed |
| US-20120123154-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123154-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | AKR7A2, AOC2, CBR1 | ALDH1A1 35/4885TDP1 4738/4885CASP3 2689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.